Man Group PLC Athenex, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.24 - $1.11 $1,737 - $8,035	-7,239 Reduced 5.05%	136,107 $37,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.91 $2,967 - $6,587	7,239 Added 5.32%	143,346 $59,000
Q4 2021 Feb 14, 2022	BUY	$1.36 - $2.94 $185,105 - $400,154	136,107 New	136,107 $185,000
Q4 2018 Feb 14, 2019	SELL	$10.24 - $15.49 $132,597 - $200,580	-12,949 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.53 - $19.97 $201,097 - $258,591	12,949 New	12,949 $201,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.